Feeling Sick on Wegovy: What the Evidence Shows

Why Wegovy causes nausea, the mechanism behind the side effect

Semaglutide activates GLP-1 receptors in the gut and brain. One of those receptors' jobs is to slow gastric emptying, the rate at which food moves from your stomach into the small intestine. That slowdown is partly responsible for reduced appetite, but it also means food sits in your stomach longer than it used to, and that unfamiliar pressure is what most people experience as nausea. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, and stomach discomfort as the most common effects, all related to this same slowing of gut motility. The reaction is strongest when semaglutide levels in the body are rising, which is why symptoms tend to peak in the days after an injection and after a dose step-up. Once your system adjusts to a stable dose, most people find the nausea eases considerably.

This is not a sign that the medicine is harming you. It is the predictable pharmacology of a GLP-1 agonist meeting a gut that has not encountered it before. That said, knowing the mechanism does not make it more comfortable, and if you are wondering whether Wegovy is making you sick in a way that feels beyond normal adjustment, it is worth understanding which symptoms are expected and which warrant a conversation with your prescriber rather than patience alone. Our guide to feeling sick on semaglutide explains how to tell the difference between typical adjustment and something that needs attention.

What the STEP 1 trial data actually show about how long it lasts

The STEP 1 trial (68 weeks, 1,961 adults with obesity, published in the New England Journal of Medicine) remains the foundational evidence base for Wegovy's side-effect profile. Around 44% of participants on semaglutide 2.4 mg reported nausea at some point during the trial, compared with 16% on placebo. Vomiting affected roughly a quarter of those on semaglutide. Critically, the majority of these episodes were mild to moderate in severity, and most resolved without people stopping treatment, the discontinuation rate due to gastrointestinal side effects was around 4.5%.

The pattern that emerged was consistent: nausea was most likely in the first 16 to 20 weeks of treatment, clustered around dose increases, and it declined over time at a stable dose. By the later phases of the trial, GI symptoms had largely settled for most participants. That trajectory matters if you are currently a few weeks in and wondering whether things will ever improve, for the majority of people, they do. If you want more detail on the broader side-effect picture beyond nausea, the full Wegovy side effects overview on this site covers the complete profile.

Practical steps that can reduce nausea while staying on treatment

NHS guidance, the Wegovy patient information leaflet, and clinical experience consistently point to the same handful of adjustments. Smaller, more frequent meals reduce the volume sitting in a stomach that is already emptying slowly. Avoiding high-fat, heavily spiced, or very rich foods in the days around your injection tends to reduce the severity of nausea. Eating slowly (pausing between mouthfuls) gives the gut signals time to register fullness before you have overeaten. Staying well hydrated matters too, particularly if vomiting has occurred, because dehydration can worsen GI symptoms and carries its own risks on GLP-1 treatment.

Timing injections for evenings can mean you sleep through the worst of any post-dose nausea, though this is a practical preference rather than a clinical requirement. If symptoms are disrupting sleep, meals, or daily function, tell your prescriber, the titration schedule exists partly to minimise this, and slowing a dose increase is sometimes the right clinical call. More detail on managing the specific experience of persistent nausea that is affecting daily life is covered separately.

When nausea signals something that needs urgent attention

Most Wegovy-related nausea is self-limiting and does not require emergency care. However, some symptoms should not be managed at home. If you are repeatedly being sick after your Wegovy injection, it is important to know which warning signs mean you should seek urgent medical help rather than waiting for symptoms to pass. Seek urgent medical help if you experience severe, persistent abdominal pain that radiates through to your back, with or without vomiting, this can be a sign of acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026 as an infrequent but serious risk. Gallbladder symptoms (sudden pain under the right ribs), signs of significant dehydration such as very dark urine, dizziness, or inability to keep any fluids down are also reasons to contact a doctor rather than wait.

If you are unsure whether what you are experiencing is routine adjustment or something more, err on the side of seeking advice. Our prescribers are available seven days a week via the support contact page, and you can also report suspected side effects directly through the MHRA Yellow Card scheme. For anyone considering Wegovy for the first time and wanting to understand the full picture before starting, speak to our prescribers through a free consultation.